Scientific deep-dive
Is Yoga Good for Weight Loss? Honest Evidence Review
Yoga alone has no pooled effect on body weight across 30 RCTs (Lauche 2016). Real value is stress, sleep, HRV, and lean-mass support for GLP-1 patients. Energy cost 150–400 kcal/h by style; below running, cycling, swimming.
TL;DR
Yoga produces little direct weight loss when used alone. The largest meta-analysis (Lauche 2016 in Preventive Medicine, 30 RCTs) found no pooled effect on body weight, and a BMI benefit only in overweight and obese participants that was not robust to bias. A 12-week trial in 60 women with abdominal obesity (Cramer 2016) found waist circumference fell 3.8 cm more with yoga than with a waiting list. Measured Hatha yoga costs about 2.2–2.5 METs, roughly 150–180 kcal/h for a 70 kg adult— below running, cycling, swimming, and HIIT.
The better-supported value of yoga is stress and well-being, plus low-impact movement for GLP-1 patients (Wegovy, Zepbound, Saxenda, Foundayo); in the SURMOUNT-1 DXA substudy about 25% of the weight lost was lean mass (Look 2025, PMID 39996356). Yoga is one of the lowest-barrier-to-entry modalities during dose titration because it is low-impact, accessible at any fitness level, and addresses the fatigue + anxiety + sleep-disruption side-effect cluster that drives GLP-1 non-adherence.
If you are choosing between modalities for direct weight loss, running, cycling, swimming, and HIIT will move the scale faster than yoga. If you are already on a GLP-1 and need a complementary practice, 2–3 yoga sessions per week (preferably Vinyasa or Power for higher energy cost) paired with 2 resistance-training sessions, 150+ minutes/week aerobic activity, and 1.2–1.6 g/kg/day protein is the evidence-supported recipe — a good fitness app for weight loss makes that weekly mix easier to program and track.
The full pairing protocol lives in our exercise-pairing hub for GLP-1 lean-mass preservation — this article is the dedicated review of yoga specifically.
Magnitude comparison vs GLP-1s
Magnitude comparison
Total body-weight reduction at trial endpoint — yoga (modality, not pharmacotherapy) compared with FDA-approved GLP-1 weight-loss medications. Lauche 2016 found no significant pooled effect of yoga on body weight, so the yoga bar is shown at zero; STEP-1 semaglutide 2.4 mg at 68 wk; SURMOUNT-1 tirzepatide 15 mg at 72 wk.[1][11][12]
- Yoga alone (Lauche 2016 meta-analysis, 30 RCTs)0.0 % TBWLZero on this scaleNo significant pooled effect on body weight
- Wegovy — semaglutide 2.4 mg (STEP-1, 68 wk)14.9 % TBWL
- Zepbound — tirzepatide 15 mg (SURMOUNT-1, 72 wk)20.9 % TBWL
Yoga is not in the magnitude class of FDA-approved obesity pharmacotherapy. Its evidence-based role is as a complementary modality — stress reduction, well-being, and some muscle loading when paired with adequate protein and resistance training. For GLP-1 patients (about 25% of the weight lost was lean mass in the SURMOUNT-1 DXA substudy), yoga is one of the lowest-barrier-to-entry tools in the adherence-and-quality-of-life toolkit; it is not a substitute for the GLP-1 injection driving the bulk of total weight loss.
1. Energy cost varies 3-4× across yoga styles
The single biggest reason yoga is not a primary weight-loss modality is the modest per-session caloric cost — and the second biggest reason is that “yoga” covers a wide metabolic range depending on style. Clay and colleagues (2005, PMID 16095417) measured a 30-minute Hatha routine in 26 women at 2.17 METs and 2.23 kcal/min, 53% lower than walking at 3.5 mph, and called it very light intensity. Hagins and colleagues (2007, PMID 18053143) measured a 56-minute beginner Hatha session in 20 practitioners at 2.5 METs and concluded that it does not meet recommended levels of physical activity for improving or maintaining health or cardiovascular fitness. Flow-based styles (Vinyasa, Power, Ashtanga) run substantially higher because of continuous transition between poses and prolonged standing-pose endurance. Only the Hatha and walking rows in the table below come from direct measurement in the cited studies; the other rows are rough estimates for orientation.
| Style | Approx. kcal/hour (70 kg adult) | Typical MET range | Notes |
|---|---|---|---|
| Yin / Restorative | 100–150 kcal | 1.5–2.5 METs | Long-held passive poses; estimate |
| Hatha | 150–180 kcal | 2.2–2.5 METs | Clay 2005 + Hagins 2007 direct measurement |
| Iyengar | 150–200 kcal | 2.5–3 METs | Alignment-focused; longer holds, props; estimate |
| Hot yoga (Bikram, 26&2) | 200–350 kcal | 3–5 METs | Heart rate elevated by heat; estimate |
| Vinyasa | 250–350 kcal | 3.5–5 METs | Continuous flow; estimate |
| Power / Ashtanga | 300–400 kcal | 4–6 METs | Faster flow; estimate |
| Walking 3.5 mph (5.6 km/h) | ~320 kcal | ~4.6 METs | Derived from Clay 2005 (Hatha was 53% lower) |
| Moderate cycling | 400–500 kcal | 5.5–7 METs | Moderate aerobic; estimate |
| Swimming (moderate) | 450–550 kcal | 6–8 METs | Low joint load; estimate |
| Running 6 mph (10 km/h) | 600–700 kcal | 10–11 METs | Vigorous aerobic; estimate |
Magnitude comparison
Approximate energy expenditure per hour by exercise modality, 70 kg adult. Only Hatha (Clay 2005, Hagins 2007) and walking (derived from Clay 2005) come from direct measurement; the other bars are rough estimates.[6][7]
- Yin / Restorative yoga125 kcal/h
- Hatha yoga165 kcal/h
- Hot yoga (Bikram)275 kcal/h
- Walking 3.5 mph320 kcal/h
- Vinyasa yoga300 kcal/h
- Power / Ashtanga yoga350 kcal/h
- Moderate cycling450 kcal/h
- Swimming (moderate)500 kcal/h
- Running 6 mph650 kcal/h
For a typical 60-minute yoga class, the Hatha range is roughly 150–180 kcal and the Power/Ashtanga range is roughly 300–400 kcal — the same range as a 30-minute moderate run, using the rough estimates above. To burn an extra 500 kcal a day (a common planning target) through yoga alone, a 70 kg patient would need about 3 hours of Hatha a day — not practical or recommended.
Why the caloric range is wide: body weight, intensity (beginner vs advanced), style, instructor pacing, and time-under-tension all affect the metabolic cost. A heavier patient burns more per hour at the same MET level, and a vigorous Vinyasa class with continuous Chaturanga costs more than the measured Hatha sessions, but the faster styles have not been measured in the studies cited here.
2. What the meta-analyses and RCTs actually show
2.1 Lauche 2016 (PMID 27058944) — the strongest synthesis
Lauche, Langhorst, Lee, Dobos, and Cramer (Preventive Medicine, 2016) performed a systematic review and meta-analysis of yoga effects on weight-related outcomes covering 30 randomized controlled trials with 2,173 participants. Key findings:
- No effect on body weight, BMI, body fat percentage, or waist circumference was found across the pooled studies.
- In overweight or obese participants, yoga lowered BMI compared with usual care (SMD −0.99), and in healthy adults it improved waist/hip ratio (SMD −1.00).
- Those effects were not robust against selection bias, and publication bias could not be ruled out.
- No intervention-related adverse events were reported.
2.2 Cramer 2016 RCT (PMID 27776622) — the abdominal-obesity trial
Cramer and colleagues (Deutsches Arzteblatt International, 2016) randomized 60 women with abdominal obesity (waist circumference ≥88 cm) in a 2:1 ratio to 12 weeks of yoga or a waiting list. Key results:
- Waist circumference, the primary endpoint, fell 3.8 cm more with yoga than on the waiting list.
- There were moderate differences in waist/hip ratio, body weight, BMI, body fat percentage, well-being and subjective stress.
- Participants averaged 30.2 hours of supervised yoga, none followed a low-calorie diet, and there were no serious adverse events.
2.3 Telles 2014 RCT (PMID 24878827) — yoga vs walking head-to-head
Telles and colleagues (Medical Science Monitor, 2014) randomized 68 overweight and obese adults to 15 days of supervised yoga or walking, 90 minutes a day, in a residential setting where both groups ate the same diet. Key results:
- Both groups showed significant within-group reductions in BMI, waist and hip circumferences, lean mass, body water, and total cholesterol.
- The yoga group also increased serum leptin and lowered LDL cholesterol; the walking group lowered adiponectin and triglycerides.
- The changes reported were within each group, so the trial does not show that one modality beat the other, and 15 days is too short to say much about lasting weight loss.
2.4 The pattern across the literature
Across the meta-analysis and individual RCTs, yoga produces little or no reliable change in scale weight, with some trials showing changes in waist circumference. That fits the modest per-session caloric cost: yoga alone is unlikely to create a large calorie deficit. Any effects on body composition through bodyweight loading, stress or sleep are plausible but not established by these trials.
3. The real strength: stress and well-being
Yoga's strongest evidence base is not weight loss — it is the mind-body pathway: chronic stress reduction and well-being. Claims about sleep and heart-rate variability (HRV) are weaker, as the HRV review below shows.
3.1 Hartfiel 2011 + 2012 — workplace stress trials
Hartfiel and colleagues published two complementary workplace- yoga RCTs in the UK. Hartfiel 2011 (PMID 20369218, Scandinavian Journal of Work, Environment & Health) randomized 48 university employees to 6 weeks of Dru Yoga (one 60-minute class per week) or a waiting list. The yoga group scored better on seven of eight mood and well-being measures, including clear-mindedness, composure, energy, confidence, and self-confidence during stressful situations.
Hartfiel 2012 (PMID 23012344, Occupational Medicine) randomized 74 local-government employees (37 per group) to 8 weeks of one 50-minute Dru Yoga session a week plus a 20-minute home DVD, or no intervention, and reported significantly greater reductions in perceived stress and back pain in the yoga arm. The dose was modest and still produced detectable effects, although both trials were small and the authors called for larger ones.
3.2 Posadzki 2015 — HRV meta-analysis
Posadzki and colleagues (Applied Psychophysiology and Biofeedback, 2015, PMID 26059998) meta-analyzed 14 RCTs of yoga interventions on heart-rate-variability outcomes. Only two trials were of acceptable quality; ten reported a favorable effect on some HRV measure while nine did not, and the two pooled analyses showed no significant effect. The authors concluded the results provide no convincing evidence that yoga changes HRV.
3.3 Indirect weight-loss mechanism via stress and sleep
The chronic-stress-to-visceral-adiposity pathway has three mechanistic components, each well-described in physiology literature:
- HPA-axis activation and cortisol — chronic stress elevates cortisol, which preferentially promotes central (visceral) adipogenesis and antagonizes insulin sensitivity in adipose tissue.
- Stress-eating behavior — cortisol- mediated reward-system changes drive preference for energy- dense palatable foods (the “comfort food” phenomenon).
- Sleep disruption — chronic stress fragments sleep architecture, which independently increases hunger (via ghrelin elevation and leptin suppression), caloric intake, and weight gain.
If yoga's stress-reduction effect eases these pathways, the benefit for weight would be small and indirect. The trials above did not measure it, so treat this as a plausible mechanism rather than a demonstrated effect, and not a substitute for a sustained caloric deficit.
4. Where yoga fits in ACSM and HHS physical-activity guidelines
4.1 ACSM 2009 (Donnelly, PMID 19127177)
The American College of Sports Medicine 2009 position stand on physical activity and weight loss (Donnelly et al., Medicine & Science in Sports & Exercise) is the canonical reference for exercise volume and clinically significant weight loss. Key thresholds:
- 150–250 min/week of moderate-intensity physical activity is effective to prevent weight gain but provides only modest weight loss.
- ≥250 min/week of moderate-intensity activity is required for clinically significant weight loss.
- After weight loss, observational studies link >250 min/week with better weight maintenance, although no well-designed RCTs have tested this.
Typical yoga weekly volume (2–3 sessions × 60–90 min = 120–270 min/week) sits at or just below the 250 min/week mark — but most of that volume is at light-intensity (Hatha, Iyengar, Yin) rather than moderate-intensity, which weakens the calorie-deficit arithmetic. This is the mechanistic reason yoga produces modest direct weight loss: it cannot easily accumulate enough weekly minutes at sufficient intensity to clear the ACSM threshold without supplementing with additional aerobic activity.
4.2 HHS Physical Activity Guidelines for Americans (Piercy 2018, PMID 30418471)
The 2018 HHS Physical Activity Guidelines for Americans, published in JAMA, define the federal recommendations for adults:
- 150–300 min/week moderate-intensity OR 75–150 min/week vigorous-intensity aerobic activity (or an equivalent combination).
- Muscle-strengthening activities ≥2 days/week that work all major muscle groups.
The guidelines mention yoga as a multicomponent activity for older adults (one that can combine balance, muscle-strengthening and aerobic work) and note that some types of yoga are light intensity on an absolute scale. A session can help with the muscle-strengthening goal when it works the major muscle groups hard (standing-pose endurance, planks, Chaturanga). Yoga rarely satisfies the aerobic-activity criterion on its own except perhaps in vigorous flow practice; patients who use yoga as their only modality typically need to add walking, cycling, swimming, or running to hit the ≥150 min/week threshold.
The practical guideline-alignment recipe for a patient using yoga as part of a weight-loss program:
- Yoga 2–3 sessions/week — preferably Vinyasa or Power for higher energy cost; can help with the muscle-strengthening goal and with stress.
- Aerobic activity 150–250+ min/week — walking, cycling, swimming, or running. This is the lever that moves you toward the ACSM 2009 weight-loss range and the HHS aerobic target.
- Caloric restriction — the necessary partner to exercise volume; yoga alone cannot create a sustained caloric deficit at typical session frequency.
5. Common bad takes about yoga and weight loss
5.1 “Hot yoga burns 1,000 calories per class”
We found no metabolic measurement that supports it, and none of the studies cited here measured heated yoga. The heat raises heart rate and perceived effort, but a faster heart rate is not the same as more fat burned. The drop on the scale right after a hot-yoga session is mostly fluid lost as sweat, and it comes back when you rehydrate.
5.2 “Yoga is cardio”
Usually no. Hagins 2007 (PMID 18053143) directly measured a beginner Hatha session at 2.5 METs on average — significantly below the 3.0 MET moderate-intensity reference from ACSM and AHA. The sun-salutation portion came close to moderate intensity, and the authors concluded the session as a whole did not meet recommendations for improving cardiovascular fitness. Faster flow styles may reach moderate intensity for portions of the session — but a typical “yoga is my cardio” routine of twice-weekly Hatha will not produce the cardiovascular- fitness adaptations of dedicated aerobic exercise. Yoga is best classified as muscle-strengthening + flexibility + mind-body activity, with a flow-style subset that overlaps into moderate aerobic intensity.
5.3 “Stretching is a workout”
Stretching alone is not a workout for weight-loss purposes. Passive static stretching burns little more than sitting, and Yin yoga, which is primarily long-held passive stretches, is likely in the same low range. These styles have real value for flexibility, joint range of motion, and recovery — but they are not energy-balance-relevant at a scale that affects weight loss. Patients using Yin or Restorative yoga exclusively should pair the practice with higher-intensity modalities if direct weight loss is the goal.
5.4 “Yoga replaces strength training for lean-mass preservation”
Not for the muscles that matter most in GLP-1 sarcopenic-obesity risk. Yoga provides bodyweight-against-gravity loading that produces some muscle-protein-synthesis stimulus, particularly in the shoulder girdle, core, and lower-extremity stabilizers. But the quadriceps, hamstrings, gluteals, and lats — the high-mass muscles that account for the bulk of fat-free mass on DXA — require progressive resistance loading beyond bodyweight to maintain or grow during a substantial caloric deficit. Yoga is a complementary practice to resistance training, not a substitute. The recommended GLP-1 pairing remains 2–3 yoga sessions + 2 resistance-training sessions per week.
6. The practical GLP-1 case for yoga
The strongest practical case for yoga as part of a weight-loss program is in patients already on GLP-1 therapy — semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro), liraglutide (Saxenda, Victoza), or orforglipron (Foundayo) — where yoga's low-impact, accessible- at-any-fitness-level nature lines up with the dose-titration window in which patients commonly experience fatigue, nausea, and reduced exercise tolerance.
6.1 Why yoga pairs well with GLP-1 dose titration
- Low impact — no joint loading at the high-eccentric magnitude of running or HIIT; tolerable on days when GLP-1-induced nausea or fatigue makes high- intensity exercise unfeasible.
- Accessible at any fitness level — chair yoga, restorative yoga, and gentle Hatha are appropriate for patients de-conditioned at baseline or in the early titration window when energy reserves are low.
- Stress and well-being — Hartfiel 2011 + 2012 found benefits in small workplace trials; whether the same applies to medication-related anxiety has not been tested.
- Relaxation on rough days — gentle styles give patients something to do when nausea or fatigue rules out harder exercise. We do not review yoga and sleep trials here, and the HRV evidence is weak (Posadzki 2015, PMID 26059998).
6.2 Recommended weekly pairing for GLP-1 patients
| Component | Frequency | Purpose | Reference |
|---|---|---|---|
| Yoga (Vinyasa or Power preferred) | 2–3 sessions/week, 45–60 min each | Stress, well-being, some muscle loading; tolerable in the titration window | Piercy 2018 (PMID 30418471) |
| Resistance training | 2–3 sessions/week, full-body or upper/lower split | Skeletal-muscle hypertrophy / preservation; primary lean-mass-preservation lever | Donnelly 2009 (PMID 19127177) |
| Aerobic activity | 150–250 min/week moderate intensity | Caloric deficit lever; HHS aerobic criterion | Piercy 2018 (PMID 30418471) |
| Protein intake | 1.2–1.6 g/kg/day | Muscle protein synthesis substrate; pairs with resistance + yoga loading | See protein guide |
The pairing recipe is the same as for Pilates and tai chi walking — mind-body modalities sit in the same role (complementary, not primary). What distinguishes yoga is its stress and flexibility benefits and the accessibility during difficult titration windows. Patients who want one modality they can do on a high-nausea day without skipping their session should default to gentle Hatha or restorative yoga; on higher-energy days, Vinyasa or Power yoga doubles as partial cardiovascular work.
7. Bottom line
If your question is “is yoga good for weight loss?” the honest answer is: not much, by itself (no pooled effect on body weight across 30 RCTs in Lauche 2016). Yoga is not a primary weight-loss intervention and will not produce magnitude in the FDA-approved-GLP-1 range (15–21% TBWL).
If your question is “should I do yoga as part of a weight-loss program?” the honest answer is: yes, for stress, well-being, flexibility, and some bodyweight muscle loading. This is particularly valuable for GLP-1 patients managing nausea, fatigue, anxiety, and sleep disruption during dose titration.
If you want one modality that does the most for direct weight loss, it is not yoga. Running, cycling, swimming, and HIIT will move the scale faster. Resistance training will preserve more lean tissue. Yoga wins on stress, well-being, and accessibility — an important set of outcomes, but not the same as caloric deficit.
Pair yoga with a structured aerobic program, resistance training 2–3 times per week, 1.2–1.6 g/kg/day protein, and (for qualifying patients) FDA-approved anti-obesity medication, and you have the evidence-supported recipe. Yoga is a real, useful, low-cost, low-risk component of that recipe — just not the load-bearing one.
Related research and tools
- Is Pilates good for weight loss? — sister mind-body modality. The Pilates evidence is mixed: Wang 2021 (PMID 33776797) pooled 11 RCTs in adults with overweight or obesity and found −2.4 kg, while Aladro-Gonzalvo 2012 (PMID 22196436) found poor evidence and Cavina 2020 (PMID 32396869) found mat Pilates no better than control or other training. Pilates emphasizes core-stabilizer and postural muscle loading; yoga emphasizes whole-body flexibility and breath. Same complementary-not-primary role for weight loss.
- Does tai chi walking cause weight loss? — sister low-intensity mind-body modality. Tai chi METs 2.3–3.2 (Lyu 2020 PMID 32760589); Hui 2009 (PMID 19258625): “walking exercise elicited about 46% higher metabolic cost than Tai Chi exercise.” Tai chi's strongest evidence is fall prevention (Sherrington 2019 Cochrane PMID 30703272: 20% fewer people fell, high-certainty evidence); yoga's better-supported benefit is stress and well-being. Both occupy the same complementary role.
- Exercise pairing for GLP-1 lean-mass preservation (hub) — the broader pairing protocol this article links up to. Includes the full S-LiTE trial coverage, resistance- training programming, and the muscle-protein-synthesis primer.
- What to eat on a GLP-1 (protein guide) — the dietary side of the lean-mass-preservation pair; food choices that meet the 1.2–1.6 g/kg/day protein target.
- GLP-1 fatigue: mechanism and management — covers the titration-window fatigue that makes high-intensity exercise difficult and yoga uniquely tolerable.
- Is running good for weight loss? — the higher-energy-cost aerobic counterpart. Running costs several times more per hour than measured Hatha yoga (Clay 2005, Hagins 2007); STRRIDE AT/RT (Willis 2012 PMID 23019316) and Foster-Schubert 2012 (PMID 21494229) are the load-bearing trials. Same complementary-not-primary role vs FDA-approved AOMs; different secondary-benefit profile (running wins on cardio and fat loss; yoga wins on stress and well-being).
- GLP-1 protein & macro calculator (tool) — generates a per-day protein target based on body weight and activity level.
- GLP-1 exercise pairing configurator (tool) — builds a personalized weekly yoga + resistance + aerobic schedule based on your starting fitness and time budget.
References
- Lauche R, Langhorst J, Lee MS, Dobos G, Cramer H. A systematic review and meta-analysis on the effects of yoga on weight-related outcomes. Prev Med. 2016 Jun. PMID 27058944.
- Cramer H, Thoms MS, Anheyer D, Lauche R, Dobos G. Yoga in Women With Abdominal Obesity — a Randomized Controlled Trial. Dtsch Arztebl Int. 2016 Sep 30. PMID 27776622.
- Telles S, Sharma SK, Yadav A, Singh N, Balkrishna A. A comparative controlled trial comparing the effects of yoga and walking for overweight and obese adults. Med Sci Monit. 2014 May 31. PMID 24878827.
- Hartfiel N, Havenhand J, Khalsa SB, Clarke G, Krayer A. The effectiveness of yoga for the improvement of well-being and resilience to stress in the workplace. Scand J Work Environ Health. 2011 Jan. PMID 20369218.
- Hartfiel N, Burton C, Rycroft-Malone J, Clarke G, Havenhand J, Khalsa SB, Edwards RT. Yoga for reducing perceived stress and back pain at work. Occup Med (Lond). 2012 Dec. PMID 23012344.
- Clay CC, Lloyd LK, Walker JL, Sharp KR, Pankey RB. The metabolic cost of hatha yoga. J Strength Cond Res. 2005 Aug. PMID 16095417.
- Hagins M, Moore W, Rundle A. Does practicing hatha yoga satisfy recommendations for intensity of physical activity which improves and maintains health and cardiovascular fitness? BMC Complement Altern Med. 2007 Nov 30. PMID 18053143.
- Posadzki P, Kuzdzal A, Lee MS, Ernst E. Yoga for Heart Rate Variability: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Appl Psychophysiol Biofeedback. 2015 Sep. PMID 26059998.
- Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009 Feb. PMID 19127177.
- Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The Physical Activity Guidelines for Americans. JAMA. 2018 Nov 20. PMID 30418471.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18. PMID 33567185.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21. PMID 35658024.
- Look M, Dunn JP, Kushner RF, Cao D, Harris C, Gibble TH, Stefanski A, Griffin R. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025 May. PMID 39996356.
Frequently Asked Questions
Further reading
Where to get tirzepatide (Mounjaro / Zepbound) safely: vetted online providers
Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
CoreAge Rx
Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Read full review →From $129/mo (“starting at” price)
Get started →From $129/mo (sale price)
Get started →Gala
Compounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping
Read full review →From $179/mo (prepaid plan rate)
Get started →